Funding
← Back to your selection

Illumina Ventures

Activity from announced rounds

All recorded activity
Rounds participated in
2
Confirmed lead rounds
0
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$275M
1 disclosed · full round size, not this investor’s share

By stage

Series A1
Series C+1

By primary sector

Agritech1
Biotech1

By country

United States2

Rounds

2 in all activity
Robigo

Robigo engineers biological crop-protection solutions that use targeted microbes to control plant pathogens while preserving beneficial organisms.

UndisclosedSeries A
Participant
Encoded Therapeutics Inc.

Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome.

$275MSeries F
Participant